IPP Bureau

BD, Suttons Creek partner to streamline combination product development
BD, Suttons Creek partner to streamline combination product development

By IPP Bureau - April 30, 2026

The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration

RPG Life Sciences reports Rs 707.5 crore revenue in FY26, 8% annual growth
RPG Life Sciences reports Rs 707.5 crore revenue in FY26, 8% annual growth

By IPP Bureau - April 30, 2026

In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth

Syngene reports FY26 revenue of Rs 3,739 Cr, up 3%; Q4 revenue at Rs 1,037 Cr
Syngene reports FY26 revenue of Rs 3,739 Cr, up 3%; Q4 revenue at Rs 1,037 Cr

By IPP Bureau - April 30, 2026

Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities

Sahajanand Medical Technologies secures ISO 50001:2018 certification for Surat, Hyderabad facilities
Sahajanand Medical Technologies secures ISO 50001:2018 certification for Surat, Hyderabad facilities

By IPP Bureau - April 30, 2026

Certification reinforces energy efficiency, sustainability goals, and green manufacturing across SMT’s Surat and Hyderabad facilities

Solara announces closure of US FDA inspection at Puducherry facility
Solara announces closure of US FDA inspection at Puducherry facility

By IPP Bureau - April 30, 2026

The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets

Wanbury's Patalganga site clears Korea FDA inspection with zero observations
Wanbury's Patalganga site clears Korea FDA inspection with zero observations

By IPP Bureau - April 30, 2026

Patalganga plant received zero observation from USFDA earlier

KIMS enters into MoU for strategic clinical collaboration
KIMS enters into MoU for strategic clinical collaboration

By IPP Bureau - April 30, 2026

The association is intended to strengthen healthcare delivery standards, particularly in Oncology services, and enhance patient care outcomes

Pfizer drug delivers breakthrough in late-stage blood cancer trial
Pfizer drug delivers breakthrough in late-stage blood cancer trial

By IPP Bureau - April 30, 2026

Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis

Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout
Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout

By IPP Bureau - April 30, 2026

The agreement could rise to $900 million if key commercial milestones are met

Zealand Pharma and Roche charge into Phase 3 with obesity drug bet
Zealand Pharma and Roche charge into Phase 3 with obesity drug bet

By IPP Bureau - April 30, 2026

The Danish biotech company confirmed the global study will begin in the second half of 2026

Gen Z split on AI as global study reveals rising tech optimism
Gen Z split on AI as global study reveals rising tech optimism

By IPP Bureau - April 30, 2026

Health innovations are viewed more positively than food and agricultural technologies

Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy
Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy

By IPP Bureau - April 29, 2026

Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights

Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology
Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology

By IPP Bureau - April 29, 2026

The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use

Sanofi Consumer Healthcare reports 33% revenue growth in Q1 FY26; PAT rises 36%
Sanofi Consumer Healthcare reports 33% revenue growth in Q1 FY26; PAT rises 36%

By IPP Bureau - April 29, 2026

Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market

Gleneagles BGS Hospital launches HEAL Health Card to expand access to affordable care
Gleneagles BGS Hospital launches HEAL Health Card to expand access to affordable care

By IPP Bureau - April 29, 2026

The initiative is designed to benefit patients as well as healthcare providers by streamlining access to consultations, diagnostics, and essential care services

Latest Stories

Interviews

Packaging